We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
34 hedge funds and large institutions have $43.5M invested in Zevra Therapeutics in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 5
101% more capital invested
Capital invested by funds: $21.7M → $43.5M (+$21.8M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
10% more funds holding
Funds holding: 31 → 34 (+3)
Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.78%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
9
Increased
11
Reduced
5
Closed
6
Calls
$28K
Puts
–
Net Calls
+$28K
Net Calls Change
+$28K
Top Buyers
| 1 |
IG
ING Group
Amsterdam,
Netherlands
|
+$843K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$745K |
| 3 |
JP Morgan Chase
New York
|
+$604K |
| 4 |
Renaissance Technologies
New York
|
+$546K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$138K |
Top Sellers
| 1 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
-$1.55M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$603K |
| 3 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$289K |
| 4 |
MC
Menta Capital
San Francisco,
California
|
-$109K |
| 5 |
BlackRock
New York
|
-$76.4K |
